FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers GlobeNewswire November 20, 2025 HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential […]

To support its third consecutive year of over 50% premium growth, Obsidian Insurance Holdings, Inc. (“Obsidian”), the holding company for Obsidian Specialty Insurance Company, Obsidian Insurance Company, and Obsidian Pacific Insurance Company, has increased surplus in its writing companies raising capital through a successful senior notes issuance and additional capital investment from its existing equity

Northland Power Provides Strategic Update Ahead of 2025 Investor Day GlobeNewswire November 20, 2025 TORONTO, Nov. 20, 2025 (GLOBE NEWSWIRE) — Northland Power Inc. (“Northland” or the “Company“) (TSX: NPI) today announced its strategic update and 2030 outlook. The Company's executive team will provide further details on Northland's strategic direction, growth priorities, and key initiatives

Aris Mining Corporation (Aris Mining or the Company) (TSX: ARIS) (NYSE-A:ARMN) announces that it has entered into a binding term sheet to acquire the remaining 49% interest in the Soto Norte joint venture in Colombia from MDC Industry Holding Company LLC (Mubadala). The transaction includes the termination at closing of the associated precious metals stream

Richmond, Virginia, Nov. 20, 2025 (GLOBE NEWSWIRE) — Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), announced today that its Co-Founder and Chief Executive Officer, Dr. Eric S. Edwards, M.D., Ph.D., testified before the United States Senate Special Committee on Aging during a full committee hearing titled “Made in America: Restoring

Global Hyaluronic Acid in Healthcare Market to Reach $10.5 Billion by 2030 “A Comprehensive Analysis of Hyaluronic Acid's Expanding Applications in Clinical Practice, Highlighting Innovations in Viscosupplementation, Aesthetic Medicine, and the Growing Competition from Alternative Therapies” GlobeNewswire November 20, 2025 Boston, Nov. 20, 2025 (GLOBE NEWSWIRE) — According to the latest study from BCC Research,

Phlow Corp. CEO Outlines Path to Pharmaceutical Sovereignty in Testimony Before U.S. Senate GlobeNewswire November 20, 2025 Richmond, Virginia, Nov. 20, 2025 (GLOBE NEWSWIRE) — Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), announced today that its Co-Founder and Chief Executive Officer, Dr. Eric S. Edwards, M.D., Ph.D., testified before the

The partnership bridges sales planning and incentive compensation management as the Sales Performance Management (SPM) market surges 16% annually. LINEN Cloud, a Silicon Valley-based AI and no-code Sales Planning platform and Performio, a global leader in Incentive Compensation Management (ICM), today announced a strategic partnership designed to unify territory and quota planning, and incentive compensation

(OTC US:OTLC),(Other OTC:OTLC), SAN DIEGO, Nov. 20, 2025 (GLOBE NEWSWIRE) — via IBN — Oncotelic Therapeutics, Inc. (OTLC) today announces that its joint venture partner, GMP Bio, has completed an independent third-party valuation of its drug development pipeline. The preliminary valuation, conducted by Frost & Sullivan (Hong Kong), estimates the potential value of the joint

RoviSys, a leading independent provider of comprehensive automation and information solutions, today announce the appointment of Matt Knott and Matt Cingcade as co-presidents of the company. Their appointments follow the conclusion of ten-year terms by John Turk and Joe Maukonen, who have guided the organization through a decade of significant growth and transformation. Founded in